Congenital myopathies

Current Neurology and Neuroscience Reports

Volumn 8, Issue 1, 2008, Pages 73-79

  D'Amico, Adele ^b   Bertini, Enrico ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL;

CENTRAL CORE DISEASE; CENTRONUCLEAR MYOPATHY; CLINICAL FEATURE; CONGENITAL FIBER TYPE DISPROPORTION MYOPATHY; DISEASE CLASSIFICATION; GENE MUTATION; GENETIC DISORDER; HUMAN; HYALINE BODY MYOPATHY; INCIDENCE; MOLECULAR GENETICS; MULTIMINICORE DISEASE; MYOPATHY; NEMALINE MYOPATHY; NEUROMUSCULAR DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; REVIEW; RISK FACTOR;

DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MOLECULAR BIOLOGY; MUSCLE FIBERS; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUTATION; MYOPATHIES, STRUCTURAL, CONGENITAL;

EID: 38649099761     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-008-0012-3     Document Type: Review

References (50)

1. Fardeau M, Tome F: Congenital myopathies. In Myology. Edited by Engel AG, Franzini-Armstrong C. New York: McGraw-Hill; 1994:1487-1533
2. Wallgren-Pattersson C, Laing NG: Report of the 70th ENMC International Workshop: nemaline myopathy, 11-13 June 1999, Naarden, The Netherlands. Neuromuscul Disord 2000, 10:299-306.
3. Wilson MC, Kolsky MP, Chandra R: Nemaline myopathy with severe neonatal hypotonia and total ophthalmoplegia: a case report. J Pediatr Ophthalmol Strabismus 1998, 35:174-176.
4. Wright RA, Plant GT, Landon DN, Morgan-Hughes JA: Nemaline myopathy: an unusual cause of ophthalmoparesis. J Neuro-ophthalmol 1997, 17:39-43.
5. D'Amico A, Graziano C, Pacileo G, et al.: Fatal hypertropic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutation. Neuromuscul Disord 2006, 10:548-552.
6. Scacheri PC, Hoffman EP, Fratkin JD, et al.: A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy. Neurology 2000, 55:1689-1696.
7. Scelsi R, Lombardi M, Banfi P, et al.: Acquired rod-body myopathy associated with human immunodeficiency virus infection. Ital J Neurol Sci 1990, 11:609-613.
8. Wallgren-Pettersson C, Laing NG: 138th ENMC Workshop: nemaline myopathy, 20-22 May 2005, Naarden, The Netherlands. Neuromuscul Disord 2006, 16:54-60.
9. Nowak KJ, Sewry CA, Navarro C, et al.: Nemaline myopathy caused by absence of alpha-skeletal muscle actin. Ann Neurol 2007, 61:175-184.
10. Laing NG, Wilton SD, Akkari PA, et al: A mutation in the alpha-tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1. Nat Genet 1995, 9:75-79.
11. Durling HJ, Reilich P, Müller-Höcker J, et al.: De novo missense mutation in a constitutively expressed exon of the slow alpha-tropomyosin gene TPM3 associated with atypical, sporadic case of nemaline myopathy. Neuromuscul Disord 2002, 12:947-951.
12. Tan P, Briner J, Boltshauser E, et al.: Homozygosity for a nonsense mutation in the alpha-tropomyosin slow gene TPM3 in a patient with severe infantile nemaline myopathy. Neuromuscul Disord 1999, 9:573-579.
13. Wattanasirichaigoon D, Swoboda KJ, Takada F, et al.: Mutations of the slow muscle alpha-tropomyosin gene, TPM3, are a rare cause of nemaline myopathy. Neurology 2002, 59:613-617.
14. Donner K, Ollikainen M, Ridanpää M, et al.: Mutations in the beta-tropomyosin (TPM2) gene in two families diagnosed with nemaline myopathy. Neuromuscul Disord 2002, 12:151-158.
15. Fidzianska A, Badurska B, Ryniewicz B, Dembek I: "Cap disease": new congenital myopathy. Neurology 1981, 31:1113-1120.
16. Lehtokari VL, Ceuterick-de Groote C, de Jonghe P, et al.: Cap disease caused by heterozygous deletion of the beta-tropomyosin gene TPM2. Neuromuscul Disord 2007, 17:433-442.
17. Wallgren-Pettersson C, Lehtokari VL, Kalimo H, et al.: Distal myopathy caused by homozygous missense mutations in the nebulin gene. Brain 2007, 130:1465-1476.
18. Johnston J, Kelley RI, Crawford TO, et al.: A novel nemaline myopathy in the Amish caused by a mutation in troponin T1. Am J Hum Genet 2000, 67:814-882.
19. Agrawal PB, Greenleaf RS, Tomczak KK, et al.: Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin-binding protein, cofilin-2. Am J Hum Genet 2007, 80:162-167.
20. Kaindl AM, Ruschendorf F, Krause S, et al.: Missense mutations of ACTA1 cause dominant congenital myopathy with cores. J Med Genet 2004, 41:842-848.
21. Costa CF, Rommelaere H, Waterschoot D, et al.: Myopathy mutations in a-skeletal-muscle actin cause a range of molecular defects. J Cell Sci 2004, 117:3367-3377.
22. Lammens M, Moerman PH, Fryns JP, et al.: Fetal akinesia sequence caused by nemaline myopathy. Neuropediatrics 1997, 28:116-119.
23. Wallgren-Pettersson C: 72nd ENMC International Workshop: myotubular myopathy 1-3 October 1999, Hilversum, The Netherlands. Neuromuscul Disord 2000, 10:525-529.
24. Herman GE, Finegold M, Zhao W, et al.: Medical complications in long-term survivors with X-linked myotubular myopathy. J Pediatr 1999, 134:206-214.
25. Hammans SR, Robinson DO, Moutou C, et al.: A clinical and genetic study of a manifesting heterozygote with X-linked myotubular myopathy. Neuromuscul Disord 2000, 10:133-137.
26. Pierson CR, Agrawal PB, Blasko J, Beggs AH: Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy. Neuromuscul Disord 2007, 17:562-568.
27. Biancalana V, Caron O, Gallati S, et al.: Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. Hum Genet 2003, 112:135-142.
28. Bertini E, Biancalana V, Bolino A, et al.: 118th ENMC International Workshop on Advances in Myotubular Myopathy. 26-28 September 2003, Naarden, The Netherlands. (5th Workshop of the International Consortium on Myotubular Myopathy). Neuromuscul Disord 2004, 14:387-396.
29. Bitoun M, Maugenre S, Jeannet PY, et al.: Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet 2005, 37:1207-1209.
30. Nicot AS, Toussaint A, Tosch V, et al.: Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat Genet 2007, 39:1134-1139.
31. Jungbluth H, Zhou H, Sewry CA, et al.: Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord 2007, 17:338-345.
32. Magee KR, Shy GM: A new congenital non-progressive myopathy. Brain 1956, 79:610-621.
33. De Cauwer H, Heytens L, Martin JJ: 89th ENMC International Workshop: Central Core Disease. Hilversum, The Netherlands, 19-20 January 2001. Neuromuscul Disord 2002, 12:588-595
34. Romero NB, Monnier N, Viollet L, et al.: Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia. Brain 2003, 126:2341-2349.
35. Jungbluth H, Davis MR, Muller C, et al.: Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations. Neuromuscul Disord 2004, 14:785-790.
36. Jungbluth H, Beggs A, Bonnemann C, et al.: 111th ENMC International Workshop on Multi-minicore Disease. 2nd International MmD Workshop, 9-11 November 2002, Naarden, The Netherlands. Neuromuscul Disord 2004, 14:754-766.
37. Zhou H, Jungbluth H, Sewry CA, et al.: Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. Brain 2007, 130:2024-2036.
38. Ducreux S, Zorzato F, Ferreiro A, et al.: Functional properties of ryanodine receptors carrying three amino acid substitutions identified in patients affected by multiminicore disease and central core disease, expressed in immortalized lymphocytes. Biochem J 2006, 395:259-266.
39. Zhou H, Brockington M, Jungbluth H, et al.: Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies. Am J Hum Genet 2006, 79:859-868.
40. Messina S, Hartley L, Main M, et al.: Pilot trial of salbutamol in central core and multi-minicore diseases. Neuropediatrics 2004, 35:262-266.
41. Ferreiro A, Estournet B, Chateau D, et al.: Multi-minicore disease - searching for boundaries: phenotype analysis of 38 cases. Ann Neurol 2000, 48:745-757.
42. Jungbluth H, Zhou H, Hartley L, et al.: Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene. Neurology 2005, 65:1930-1935.
43. Ferreiro A, Ceuterick-de Groote C, Marks JJ, et al.: Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene. Ann Neurol 2004, 55:676-686.
44. Fidzianska A, Goebel HH, Osborn M, et al.: Mallory body-like inclusions in a hereditary congenital neuromusculular disease. Muscle Nerve 1983, 6:195-200.
45. Clarke NF, North KN: Congenital fiber type disproportion-30 years on. J Neuropathol Exp Neurol 2003, 62:977-989.
46. Banwell BL, Becker LE, Jay V, et al.: Cardiac manifestations of congenital fiber-type disproportion myopathy. J Child Neurol 1999, 14:83-87.
47. Clarke NF, Kidson W, Quijano-Roy S, et al.: SEPN1: associated with congenital fiber-type disproportion and insulin resistance. Ann Neurol 2006, 59:546-552.
48. Clarke NF, Smith RL, Bahlo M, North KN: A novel X-linked form of congenital fiber-type disproportion. Ann Neurol 2005, 58:767-772.
49. Cancilla PA, Kalyanaraman K, Verity MA, et al.: Familial myopathy with probable lysis of myofibrils in type I fibers. Neurology 1971, 21:579-585.
50. Meredith C, Herrmann R, Parry C, et al.: Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause Laing early-onset distal myopathy (MPD1). Am J Hum Genet 2004, 75:703-708.